About Aclaris (ACRS)
Aclaris Therapeutics, Inc., incorporated on July 13, 2012, is a physician-led, biopharmaceutical company focused on immuno-inflammatory diseases. The Company is focused on leveraging its experience in drug discovery and development and kinase inhibit... Read more
- USD1.46
- USD1.50
- USD1.45
- USD5.17
- -5.20%
- 18M
- 1.29k
- 1.16M
- 156M
- 1.05
- 14.20%
Stock News
4 hours ago
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc.
Yahoo
8 hours ago
Saia: Wait And See For Execution To Improve (Rating Downgrade)
SeekingAlpha
8 hours ago
Ulta Beauty: Despite Strong Performance, Take This Opportunity To Lock In Gains (Rating Downgrade)
SeekingAlpha
8 hours ago
DLocal: Emerging Market's 'Stripe' To Play Global Expansion
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
